# Investigating the Effects of QVM149 on MRI Ventilation Defects

> **NCT04206761** · PHASE3 · WITHDRAWN · sponsor: **Dr. Grace Parraga**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** QVM149
- **DRUG:** High Dose Dual Therapy (ICS/LABA)

## Key facts

- **NCT ID:** NCT04206761
- **Lead sponsor:** Dr. Grace Parraga
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** issues related to Covid-19 restrictions/shutdowns
- **Last updated:** 2021-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04206761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04206761, "Investigating the Effects of QVM149 on MRI Ventilation Defects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04206761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*